Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
October 13th, 2025
Clinical Trial Progress: Imugene Data Continues to Impress
Read More
October 12th, 2025
Positive Outcome for Dimerix from PARASOLProject Sets Up FDA Meeting
Read More
October 11th, 2025
Amplia Achieves Additional Partial Response as Data Begins to Mature
Read More
September 26th, 2025
Clinuvel Pharmaceuticals Gains Extended Use of Scenesse in Europe
Read More
September 26th, 2025
Botanix Pharmaceuticals - Profitability in Sight?
Read More
September 12th, 2025
Aroa Biosurgery — Records Third Positive Cashflow Quarter
Read More
September 11th, 2025
Clinuvel Grows Cash Balance to $224M and Progresses Phase III Vitiligo Program
Read More
August 26th, 2025
Actinogen Medical — Why Xanamem Should Deliver Positive Results in Phase IIb Alzheimer’s Disease Study
Read More
July 28th, 2025
Clever Culture Systems Secures Another Major Pharma Customer
Read More
July 26th, 2025
Imugene to Lead with Azer-cel Program into Pivotal Study Following Additional Complete and Partial Responses. Capital Raise for up to $37.5 Million Underway
Read More
July 4th, 2025
Amplia Surges 480% on Pancreatic Cancer Cures
Read More
March 26th, 2025
Actinogen Medical: Progressing its Phase IIb/III Alzheimer's Study
Read More
March 26th, 2025
Syntara Accelerates Wound Healing Program
Read More
March 26th, 2025
Blinklab Initiates Lead-In to Pivotal Study for Autism Diagnostic Aid
Read More
February 19th, 2025
Aroa Biosurgery Narrowly Misses Full-Year Guidance
Read More
February 18th, 2025
Immuron Sales Up 70% in First Half
Read More
February 18th, 2025
Leading the Way – Adalta's East to West Roadmap
Read More
January 28th, 2025
Wheels in Motion for Cogstate
Read More
January 9th, 2025
Dimerix Secures Third Licensing Deal
Read More
December 22nd, 2024
Anteris Completes Re-Domiciliation to US, Raises US$88 Million, Maintains Australian Listing
Read More
Pages
1
